Wyeth Makes Its Case For Preemption To High Court

Law360, New York (May 28, 2008, 12:00 AM EDT) -- Wyeth has filed a brief with the U.S. Supreme Court, arguing that state-law product liability claims over one of its drugs are preempted by the Food and Drug Administration's approval of the drug in a case that could have far-reaching effects on product liability suits.

The case was originally filed in 2000 by Diana Levine, a professional musician who was given an intravenous push injection of its anti-nausea drug Phenergan when she went to the hospital for a headache.

She developed gangrene because of the injection...
To view the full article, register now.